F7Y Stock Overview
Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Gaush Meditech Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.48 |
| 52 Week High | HK$5.60 |
| 52 Week Low | HK$1.97 |
| Beta | 0 |
| 1 Month Change | 13.76% |
| 3 Month Change | -37.37% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -50.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| F7Y | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 11.7% | -1.9% | -1.0% |
| 1Y | n/a | -10.8% | 2.0% |
Return vs Industry: Insufficient data to determine how F7Y performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how F7Y performed against the German Market.
Price Volatility
| F7Y volatility | |
|---|---|
| F7Y Average Weekly Movement | 11.6% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: F7Y's share price has been volatile over the past 3 months.
Volatility Over Time: F7Y's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 869 | Xinwei Liu | www.gaush.com |
Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People’s Republic of China and internationally. The company operates through Proprietary Products, Distribution, Technical, and Others segments. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology.
Gaush Meditech Ltd Fundamentals Summary
| F7Y fundamental statistics | |
|---|---|
| Market cap | €362.48m |
| Earnings (TTM) | €22.27m |
| Revenue (TTM) | €180.49m |
16.3x
P/E Ratio2.0x
P/S RatioIs F7Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| F7Y income statement (TTM) | |
|---|---|
| Revenue | CN¥1.41b |
| Cost of Revenue | CN¥714.64m |
| Gross Profit | CN¥691.60m |
| Other Expenses | CN¥518.08m |
| Earnings | CN¥173.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.17 |
| Gross Margin | 49.18% |
| Net Profit Margin | 12.34% |
| Debt/Equity Ratio | 36.5% |
How did F7Y perform over the long term?
See historical performance and comparison